Tetra Therapeutics Announces Presentation of Data from Retrospective PopulationBased Study of 56 Million Patients at the 12th Clinical Trials on Alzheimers Disease Meeting CTAD

Study Shows that TNF Blocking Agents Reduce Risk of Alzheimers Disease in Patients with Rheumatoid Arthritis or PsoriasisTetra Therapeutics a clinicalstage biopharmaceutical company developing novel treatments for patients with cognitive impairment and mem...